Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Paul O’Connor et al.|The Lancet|2016Cited by 327
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Harold Atkins et al.|JAMA Neurology|2016Cited by 103
A 15-Year Analysis of Early and Late Autologous Hematopoietic Stem Cell Transplant in Relapsed, Aggressive, Transformed, and Nontransformed Follicular LymphomaMitchell Sabloff, Lothar Huebsch, Harold Atkins et al.|Transplantation and Cellular Therapy|2007Cited by 57
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomesSheryl McDiarmid, Lothar Huebsch, Brian Hutton et al.|Bone Marrow Transplantation|2009Cited by 51
A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantationIsabelle Bence‐Bruckler, Lothar Huebsch, Christopher Bredeson et al.|Bone Marrow Transplantation|1998Cited by 48